Extensions to amino acid description
暂无分享,去创建一个
[1] A. Stary-Weinzinger,et al. Physicochemical properties of pore residues predict activation gating of CaV1.2: A correlation mutation analysis , 2010, Pflügers Archiv - European Journal of Physiology.
[2] Michel Vert,et al. Peptide-poly(L-lysine citramide) conjugates and their in vitro anti-HIV behavior. , 2009, Biomacromolecules.
[3] G. Bifulco,et al. Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. , 2009, The Journal of organic chemistry.
[4] Stanley N Cohen,et al. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. , 2008, ACS chemical biology.
[5] Kjeld Madsen,et al. Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain* , 2008, Journal of Biological Chemistry.
[6] T. Lundstedt,et al. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase , 2007, Journal of peptide science : an official publication of the European Peptide Society.
[7] Anders Karlén,et al. Focused hierarchical design of peptide libraries—follow the lead , 2007 .
[8] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[9] Marij J P Welters,et al. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy. , 2006, Advanced drug delivery reviews.
[10] Johan Gottfries,et al. The drug designer´s guide to selectivity , 2006 .
[11] P. Grivas,et al. Monoclonal antibodies in the management of solid tumors. , 2006, Current topics in medicinal chemistry.
[12] A. Gasbarrini,et al. Biological therapies for inflammatory bowel disease: research drives clinics. , 2006, Mini reviews in medicinal chemistry.
[13] A. Heck,et al. Protein Flexibility and Ligand Rigidity: A Thermodynamic and Kinetic Study of ITAM‐Based Ligand Binding to Syk Tandem SH2 , 2005, Chembiochem : a European journal of chemical biology.
[14] B. Rost,et al. Protein flexibility and rigidity predicted from sequence , 2005, Proteins.
[15] Atsushi Ikai. Local rigidity of a protein molecule. , 2005, Biophysical chemistry.
[16] Anna Linusson,et al. Multivariate design, synthesis, and biological evaluation of peptide inhibitors of FimC/FimH protein-protein interactions in uropathogenic Escherichia coli. , 2005, Journal of Medicinal Chemistry.
[17] Ing-Marie Olsson,et al. Controlling coverage of D‐optimal onion designs and selections , 2004 .
[18] J. Edward Jackson,et al. A User's Guide to Principal Components: Jackson/User's Guide to Principal Components , 2004 .
[19] Ing-Marie Olsson,et al. D-optimal onion designs in statistical molecular design , 2004 .
[20] Johan Trygg,et al. O2‐PLS, a two‐block (X–Y) latent variable regression (LVR) method with an integral OSC filter , 2003 .
[21] T. Lundstedt,et al. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.
[22] S. Wold,et al. Orthogonal projections to latent structures (O‐PLS) , 2002 .
[23] Tudor I. Oprea,et al. Chemography: the Art of Navigating in Chemical Space , 2000 .
[24] S. Wold,et al. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.
[25] S. Wold,et al. Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. , 2009, International journal of peptide and protein research.
[26] J. Edward Jackson,et al. A User's Guide to Principal Components. , 1991 .
[27] Svante Wold,et al. Multivariate Parametrization of 55 Coded and Non‐Coded Amino Acids , 1989 .
[28] S. Wold,et al. Peptide QSARS: PLS modelling and design in principal properties. , 1989, Progress in clinical and biological research.
[29] S. Wold,et al. Peptide quantitative structure-activity relationships, a multivariate approach. , 1987, Journal of medicinal chemistry.